Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

15450 Ventura Blvd. Suite 102
Sherman Oaks, CA 91403
Phone: 818-528-7776

December 18, 2014 by Alan Khadavi

Sean Parker donates $24 million to Stanford for Allergy Research

Sean Parker, tech entrepreneur, who founded Napster and was an early investor to Facebook, has made a $24 million donation to Stanford University for allergy research.  The new center will be called the Sean N. Parker Center for Allergy Research.  He is an asthma and allergy sufferer, who was limited in childhood playing sports because of those problems.  He is worried about passing his genes on to his two children.  He also has a peanut allergy which has led him to multiple trips to the emergency room for accidental ingestion.  His wife counts 14 such episodes related to this.

About 1/3 of Americans have allergies, and it is doubling every decade.  About 25% of people with food allergies will experience a near fatal episode of anaphylaxis sometime in their lives.  Currently there is no treatment for food allergies except avoidance.  There is allergy immunotherapy for environmental allergies such as trees, grass, weeds, dust mites, dog, cats and mold (among the few).  But earlier trials of immunotherapy have failed in the past for food.  The new research center hopes to advance treatment of desensitizing for food allergies.

Many other companies has recently ventured into allergies in order to determine a cure for food allergies.  Several research centers, notably Mt. Sinai in New York are successfully desensitizing to peanut allergies, but this is still in its infancy and not ready for mainstream treatment.

Allergy immunotherapy has made recent advances over the past year in the United States, with approval of the first oral immunotherapy treatment for Grass and Ragweed in 2014.  Studies are currently underway for other allergens such as dust mite and cat, and companies are hoping to get FDA approval soon.

Sean Parker’s grant hopes to identify immune markers that relate to desensitization and hopefully come up with a cure for those afflicted by food allergies.

Filed Under: Blog, Food allergy, Headlines, Immunotherapy

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

November 17, 2026

Low Dose Naltrexone for MCAS: Benefits, Risks, and Evidence

LDN for MCAS

November 13, 2026

Cardamom Allergy: Symptoms, Diagnosis, and What to Avoid

cardamom allergy

October 28, 2026

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

October 26, 2026

Which Biologic Works Best for Nasal Polyps?

best biologic for nasal polyps

October 19, 2026

Xolair vs. Omlyclo: Cost, Effectiveness, Insurance & Switching

Xolair vs Omlyclo: Cost, Effectiveness, Insurance & Switching

October 8, 2026

Tapioca Allergy: Can Cassava Cause an Allergic Reaction?

tapioca allergy

October 8, 2026

Rhapsido for Symptomatic Dermographism: An Allergist Explains the New FDA-Approved Treatment

Rhapsido for symptomatic dermographism

October 6, 2026

Most Effective Treatments for Severe Atopic Dermatitis: New Rankings

`most-effective-treatments-severe-atopic-dermatitis

October 6, 2026

Should Airlines Be Required to Carry Epinephrine? An Allergist Explains

airline epinephrine requirement

October 2, 2026

Ketotifen for MCAS: Uses, Benefits, Side Effects, and U.S. Availability

ketotifen for MCAS

Read More Posts...

Follow Us…

© 2026 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page